Researchers observed cardiotoxicity in patients undergoing long-term treatment with the experimental drug.

Several patients in the trial developed cardiotoxicities after prolonged exposure to the experimental drug.

The clinical trial was halted after researchers found the new drug to be cardiotoxic even at low doses.